Navigation Links
Punch, Rotary 90 Right Tip, 3.4 mm Straight Shaft

ProductsPunch, Rotary 90 Right Tip, 3.4 mm Straight Shaft
Company Arthrex
Item Punch, Rotary 90 Right Tip, 3.4 mm Straight Shaft
Features 
  • Extremely low profile
  • Highest U.S. made quality
  • Smooth, durable, light-weight, patented ratchet design
  • Lifetime warranty
    • Description The Series I Instrument program offers state-of-the-art quality in an instrument of extremely low profile, while maintaining strength and durability. Low profile cutting tips allow access to pathology in tight joint spaces. Series I instruments are available in just about every cutting tip style, size and angle required for large and small joint arthroscopic procedures. Arthrex offers a lifetime guarantee on materials and workmanship on every Series I Instrument.
    Info Arthrex
    Customer Service: (800) 933-7001
    Web site: http://www.arthrex.com

    Related medicine products :

    1. Punch, WideBiter Straight Tip, 3.4 mm Straight Shaft (a)
    2. Punch, WideBiter Straight Tip, 3.4 mm 15 Up Curved Shaft
    3. Punch, WideBiter Straight Tip, 3.4 mm 30 Right Curved Shaft
    4. Punch, WideBiter Straight Tip, 3.4 mm 30 Left Curved Shaft (e)
    5. Punch, WideBiter 15 Up Tip, 3.4 mm Straight Shaft AR-12240
    6. Punch, WideBiter Inverted Straight Tip, 3.4 mm 15 Up Curved Shaft
    7. Punch, WideBiter 15 Up Tip, 3.4 mm 30 Right Curved Shaft
    8. Punch, WideBiter 15 Up Tip, 3.4 mm 15 Up Curved Shaft (b)
    9. Punch, WideBiter 15 Up Tip, 3.4 mm 30 Left Curved Shaft
    10. Punch, WideBiter 90 Left Rotary Tip, 3.4 mm Straight Shaft (d)
    11. Punch, WideBiter 90 Right Rotary Tip, 3.4 mm Straight Shaft
    Breaking Medicine Technology:Ambit Biosciences Corporation Presents Phase I Clinical Results of AC220 in Patients With Acute Myeloid Leukemia at ASH Conference 2Ambit Biosciences Corporation Presents Phase I Clinical Results of AC220 in Patients With Acute Myeloid Leukemia at ASH Conference 3Ambit Biosciences Corporation Presents Phase I Clinical Results of AC220 in Patients With Acute Myeloid Leukemia at ASH Conference 4ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 2ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 3ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 4ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 5ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 6ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 7FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 2FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 3Rampant helper syndrome 9100 1Rampant helper syndrome 9100 2Virus resistant grapevines 9098 1Virus resistant grapevines 9098 2Ferns took to the trees and thrived 9095 1Ferns took to the trees and thrived 9095 2